|
pubmed:abstractText |
The majority of patients with AIDS-related non-Hodgkin's lymphoma (ARL) present with advanced disease, aggressive histological type, B-symptoms, and often with an extranodal localization. The prognosis is generally poor. The use of highly active antiretroviral therapy (HAART), in combination with chemotherapy, has improved the outcome of ARL.
|
|
pubmed:affiliation |
Institute for Haematology, Clinical Center of Serbia, University of Belgrade, School of Medicine, Koste Todorovica 2, Belgrade, Serbia.
|
